Johnson and Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc.

NEW BRUNSWICK, N.J., March 16, 2018 -- (Healthcare Sales & Marketing Network) -- Johnson & Johnson (NYSE: JNJ) today announced that it has received a binding offer from Platinum Equity, a leading private investment firm, to acquire its LifeScan business f... Devices, Monitoring, Endocrinology, Acquisitions Johnson & Johnson, LifeScan, OneTouch, blood glucose monitor, diabetes
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news